Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs
about
sameAs
Strategies for early detection of resectable pancreatic cancerMolecular detection of pancreatic neoplasia: Current status and future promisePancreatic cancer.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics.SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controlsDecreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.Molecular signatures of pancreatic cancer.Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.Update on pancreatic intraepithelial neoplasia.Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias.Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidatesInvolvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis.Identifying molecular markers for the early detection of pancreatic neoplasia.Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas.The role of epigenetic alterations in pancreatic cancer.Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.Molecular genetics of pancreatic intraepithelial neoplasia.Pancreatic cancer screeningEpigenetics and epigenetic alterations in pancreatic cancer.Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.Function and histopathology of a cell adhesion molecule TSLC1 in cancer.Molecular pathogenesis of pancreatic cancer and clinical perspectives.Genomic and transcriptional alterations of cholangiocarcinoma.New insights in the development of pancreatic cancer.LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1.CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.Effect of TSLC1 gene on proliferation, invasion and apoptosis of human hepatocellular carcinoma cell line HepG2.Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance.Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.Folate deficiency and aberrant expression of cell adhesion molecule 1 are potential indicators of prognosis in laryngeal squamous cell carcinoma.
P2860
Q24564006-FDF4EDAA-4D5B-4179-84DF-62D199A64B1BQ26777379-11091C2D-04FE-44AF-A844-B179393CD24BQ30490247-D7EDAA2B-1349-4F48-8FD7-98FEE8349938Q30504615-6F194426-BAEC-4E3B-91C0-F61C31F09BA4Q33285490-865F935F-895F-43F1-9FE8-106964425AD1Q33715802-793E1505-EE18-4864-8A5C-D530A45AE735Q33838679-C564757D-EE44-4F7F-9354-0884BE0C49E4Q33859463-C3FFB601-ABCF-4BD0-B449-3BAF52DDC996Q33898834-16996096-450B-480F-A5C4-F59E8FEF4A05Q33918801-BE88E6F7-69C0-4D66-B518-0922E78CCCCAQ34573834-1A663A81-C14F-4CBC-8B99-A28EEFCED3FDQ34826200-4308A58F-3499-4124-86CD-9409423A3C4AQ35194027-0D50335E-B6A0-4658-A0FA-31EDEEB461C0Q35798841-7E3B426C-7A09-44EA-B853-00EA4EE061A0Q36243363-56F7EF89-9D0A-4A08-B3FB-066740BE10ACQ36328508-0A2BC34E-C2CC-4759-99D2-9554ADD3FEC1Q36542823-EBA6ADEC-AFC4-480A-A747-1FE0E9291890Q36542828-7918A423-925F-4191-90E4-3A56817F7F11Q36670990-AC7C084C-8CC4-4C9B-AE6B-C4ACEF0C18E7Q36829524-4407D6B4-A691-4C2C-8BDC-E73E60660971Q36896536-3D2EB5B8-28E4-41A1-88EF-64323FEE9A3CQ37041763-2AEACC9A-B99D-4D2F-A5B1-73D0D3C066C4Q37183611-3C835AE2-E228-499D-9784-5D86D7772F83Q37844079-05C09B02-82E6-4B23-BD43-F677D15E6863Q37960816-18DCE363-EF28-48CB-8F83-A205938A9F9FQ38188515-0189A95D-2977-4CE6-9A23-39F6604939C1Q38907393-5CB31BD1-28D2-428E-8E29-C03668F793C9Q38974695-650BCD8D-92D0-48F4-A37C-7D3C8BAB5F1BQ39115893-3EF1A1D1-9CB2-475B-8AC3-C3A82ED382DDQ39427615-94D45C02-E999-4676-95DC-BD50CAA2875BQ39722420-DB8A8BB8-ECCC-4D1B-B2F8-A0763B59C213Q39817112-9145F0F7-1601-47DD-8237-1C77846DAD49Q39900606-2430C784-1DB4-44ED-AA38-086AAEA2242FQ39947213-B8114A1E-EE67-4431-9D68-8B0532A2DA72Q40034808-C43B9F5A-9814-4434-83A5-24DBD32CE014Q40039301-334BC52A-055C-421B-860C-94F01E7F4BFDQ40383838-AE592242-D6C2-40A0-82A5-916F06B6ECBEQ40494023-C5DA73CD-C432-4481-AEA8-A0218CF74F5DQ40588855-E2B716D4-9670-40AB-AA36-EA541CD44797Q41409732-40B84390-F22F-44FE-8461-7096E85D04CD
P2860
Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@ast
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@en
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@nl
type
label
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@ast
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@en
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@nl
prefLabel
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@ast
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@en
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@nl
P2093
P50
P356
P1476
Aberrant methylation of the 5' ...... manifest in high-grade PanlNs
@en
P2093
Johan G Offerhaus
Kim Walter
Noriyoshi Fukushima
Renee Altink
Tjarda Van Heek
P304
P356
10.4161/CBT.84
P407
P577
2002-05-01T00:00:00Z